News

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.

More than 10 years after his diagnosis, he’s helping other people with the same rare cancer to hold on to hope.

The NIH awarded more than $8.3 million to study 1,000 pregnant individuals with heart conditions in an effort to combat maternal mortality and morbidity.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

Dr. Rebecca Lobell shares what causes infertility and when a person should talk to their doctor about issues conceiving.

KCTV talked to Dr. Rebecca Lobell about infertility and the steps a woman can take when she is trying to conceive.

Saint Luke’s has been delivering babies for 135 years. To honor this anniversary, we are taking a look back at Kansas City through the decades.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.